PEAR Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (18 Apr 2023 @ 16:00):

Stats
Today's Volume	66.30M
Average Volume	10.09M
Market Cap	4.09M
EPS	$0 ( 2024-03-29 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0811
ATR14	$0.0310 (645.83%)

Insider Trading

Date	Person	Action	Amount	type
2023-04-10	5am Partners Iv, Llc	Sell	3 172 769	Class A Common Stock
2023-04-10	5am Partners Iv, Llc	Sell	534 855	Class A Common Stock
2023-02-15	Snow Ellen	Buy	199 864	Restricted Stock Units
2023-02-16	Snow Ellen	Buy	40 000	Restricted Stock Units
2023-02-15	Brenner Erin K.	Buy	952 380	Restricted Stock Units

INSIDER POWER
29.87
Last 97 transactions
Buy: 13 156 765 \| Sell: 6 479 057

Volume Correlation

Long: -0.32 (neutral)

Short: -0.74 (moderate negative)

Signal:(22.192) Neutral

Pear Therapeutics, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Pear Therapeutics, Inc. Correlation - Currency/Commodity

-0.81
( strong negative )

0.00
( neutral )

-0.46
( neutral )

-0.14
( neutral )

-0.04
( neutral )

Pear Therapeutics, Inc. Financials

Annual	2022
Revenue:	$12.69M
Gross Profit:	$4.51M (35.54 %)
EPS:	$-0.170

Q4	2022
Revenue:	$2.57M
Gross Profit:	$820 000 (31.97 %)
EPS:	$0.210

Q3	2022
Revenue:	$4.08M
Gross Profit:	$1.53M (37.42 %)
EPS:	$-0.250

Q2	2022
Revenue:	$3.30M
Gross Profit:	$896 000 (27.18 %)
EPS:	$0.300

Financial Reports:

No articles found.

Pear Therapeutics, Inc.

Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a software-based treatment for chronic insomnia. The company is also developing a pipeline of 14 product candidates focusing on psychiatry, neurology, and outside of central nervous system therapeutic areas, such as gastrointestinal, oncology, and cardiovascular. Pear Therapeutics, Inc. was incorporated in 2013 and is based in Boston, Massachusetts.